Nexentis Technologies Inc. (NXTS)
NASDAQ: NXTSIndustrialsAgricultural ChemicalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NXTS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.05M
- EPS (TTM)
- -$367.15
- Dividend yield
- None
- 52-week range
- 1.55 – 119.00
- Day range
- 1.55 – 1.74
- Volume / Avg
- 7.08K / 83.05K
- Beta
- —
- Shares outstanding
- 666.66K
52-week range
NXTS stock today
Shares of Nexentis Technologies (NXTS) finished lower on Nov 20 at $1.58, a drop of 7.06% or $0.12 per share, versus the S&P 500's 3.70% decline. Trading was light, with 7.08K shares changing hands, about 9% of the average daily volume. Shares are 98.7% below their 52-week high of $119.00 and 1.9% above the 52-week low of $1.55, near the bottom of the past year's range.
Nexentis Technologies has posted a net loss over the last twelve months (EPS of -$367.15), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Nexentis Technologies
Company profileNexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc.
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- CEO
- Mr. David Palach
- Headquarters
- Ness Ziona, NY
- Employees
- 7
- Website
- nexentistech.com
Financial highlights
Full financialsNexentis Technologies reported a net loss of $4.0 million, compared with a loss of $5.2 million a year earlier. Diluted earnings per share came in at -$8.61.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | — | $210.00K | $263.44K | $394.00K | $438.14K |
| Growth | — | -20.29% | -33.14% | -10.07% | +88.63% |
| Net income | $-4.00M | $-5.19M | $-6.52M | $-5.74M | $-4.82M |
| EPS (diluted) | $-8.61 | $-27.74 | $-5.43 | $10.85 | $-2.06 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 16, 2026
- EPS actual vs est.
- $-0.33 vs —
NXTS news
All NXTS news- Nexentis: MitoCareX Progresses Toward In-Vitro Evaluation Following AI-Powered Computational ScreeningGlobeNewswire
- Nexentis Announces Reverse Stock SplitGlobeNewswire
- Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with BoltzGlobeNewswire
- Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening StageGlobeNewswire
- Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway AnalysisGlobeNewswire
Nexentis Technologies peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| UANCVR Partners LP | 95.09 | -0.88% | — | vs NXTS |
| ICLICL Group Ltd. | 4.08 | -1.45% | — | vs NXTS |
| SNESSenesTech Inc. | 0.69 | +6.15% | $4.71M | vs NXTS |
| EVGNEvogene Ltd | 0.3162 | +1.02% | $5.71M | vs NXTS |
| FRTTFort Technology Inc. | 0.47 | -9.79% | $7.14M | vs NXTS |
| BIOXBioceres Crop Solutions Corp. | 0.173 | -5.41% | $11.04M | vs NXTS |
| AVDAmerican Vanguard Corporation | 0.68 | -1.48% | $20.10M | vs NXTS |
| CBUSCibus Inc. Class A | 1.21 | -1.63% | $92.73M | vs NXTS |
Indexes, lists and sector
Nexentis Technologies stock FAQ
What is Nexentis Technologies's stock price today?
NXTS last traded at $1.58 as of Nov 20, 4:00 PM EST, down 7.06% on the day. Prices are delayed at least 15 minutes.
Does Nexentis Technologies pay a dividend?
No. Nexentis Technologies does not currently pay a regular cash dividend.
Who is Nexentis Technologies's CEO?
Mr. David Palach is the chief executive officer of Nexentis Technologies Inc., which has about 7 employees.
Has NXTS ever split its stock?
Yes. The most recent NXTS stock split was a 1-for-5 split on Nov 9, 2026.
What is the NXTS 52-week high?
The 52-week high for NXTS is $119.00 and the 52-week low is $1.55. The stock is currently 98.7% below its high.